Ocunova's Seed Round

Ocunova raised a round of funding on September 21, 2017. Investors include Ben Franklin Technology Partners of Central & Northern PA.

Ocunova is an ophthalmic drug development company whose lead compound, OCU-001, is a rapid-acting and safe-to-use treatment for diabetic Dry Eye Syndrome (DES).…

Articles about Ocunova's Seed Round: